<!-- modules/module88.html -->
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Terbutaline sulfate - KMTC Pharmacology Notes</title>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Terbutaline sulfate - KMTC Pharmacology Notes</title>
    <meta name="description" content="This module covers Terbutaline sulfate, a selective beta-2 adrenergic receptor agonist, detailing their uses and nursing considerations in respiratory conditions and preterm labor.">
</head>
<body>
    <article class="learning-module" data-module="88">
        <nav class="module-nav">
            <div class="nav-links">
              <a href="../index.html">Home</a>
              <a href="module87.html">Previous</a>
              <a href="module89.html">Next</a>
            </div>
            <div class="module-progress">
              <span>Module 88 of 89</span>
            </div>
          </nav>

        <header class="module-header">
            <h1>Terbutaline sulfate</h1>
            <section class="module-objectives">
                <h2>üéØ Learning Objectives</h2>
                <ul>
                    <li>Describe Terbutaline sulfate as a selective beta-2 adrenergic receptor agonist and its primary actions.</li>
                    <li>Explain the uses of Terbutaline in treating respiratory conditions like asthma and in tocolysis for preterm labor.</li>
                    <li>Identify the contraindications, precautions, and adverse reactions associated with Terbutaline sulfate.</li>
                    <li>Detail the nursing considerations for patients receiving Terbutaline, emphasizing monitoring and patient education.</li>
                </ul>
            </section>
        </header>

        <main class="module-content">
            <section class="content-section">
                <h2>üìö Terbutaline sulfate: Selective Beta2-Adrenergic Agonist</h2>
                <div class="content-block">
                    <p><strong>Terbutaline sulfate (Bricanyl, Monovent)</strong> is a selective beta-2 adrenergic receptor agonist, primarily used for its bronchodilator effects in respiratory conditions and as a tocolytic agent to delay preterm labor. Key features of terbutaline sulfate include:</p>
                    <ul>
                        <li>Generic name: terbutaline sulfate.</li>
                        <li>Trade name: Bricanyl, Bricanyl, Monovent.</li>
                        <li>Pharmacologic class: Selective beta2-adrenergic receptor agonist, sympathomimetic.</li>
                        <li>Therapeutic class: Bronchodilator, tocolytic.</li>
                        <li>Pregnancy risk category B: Generally considered acceptable for use during pregnancy when indicated, particularly for tocolysis to manage preterm labor.</li>
                        <li>Action: Terbutaline works by selectively stimulating beta-2 (Œ≤2) adrenergic receptors, leading to:
                            <ul>
                                <li>Bronchial Smooth Muscle Relaxation: It relaxes bronchial smooth muscle, causing bronchodilation, which reduces airway resistance and improves airflow. This bronchodilator effect is particularly useful in asthma and COPD.</li>
                                <li>Inhibition of Hypersensitivity Mediators Release: It inhibits the release of hypersensitivity mediators, especially from mast cells. This action can reduce inflammation and allergic responses in the airways.</li>
                            </ul>
                        </li>
                    </ul>
                     <figure class="content-image">
                        <img src="../assets/images/KMTC_Pharmacology.jpg"
                             alt="Diagram illustrating Terbutaline's action as a selective beta-2 adrenergic receptor agonist, showing bronchodilation in the lungs and relaxation of bronchial smooth muscle."
                             width="600" height="300">
                        <figcaption>Terbutaline Sulfate: Mechanism of Action</figcaption>
                    </figure>
                </div>
            </section>

            <section class="content-section">
                <h2>üìö Indications and dosages</h2>
                <div class="content-block">
                    <section class="content-section">
                        <h3>Indications and dosages</h3>
                        <div class="content-block">
                            <ol>
                                <li>Bronchospasm in reversible obstructive airway disease: To relieve bronchospasm associated with asthma, bronchitis, emphysema, and other conditions causing reversible airway obstruction.
                                    <ul>
                                        <li>Aerosol for inhalation: Metered-dose inhaler (MDI) delivering 0.18 ‚Äì 0.2 mg per inhalation (puff). Typically 1-2 inhalations every 4 ‚Äì 8 hours as needed for asthma symptoms.</li>
                                        <li>Solution for inhalation: Solution for nebulization, 1.25 mg in 2 ‚Äì 5 ml of saline, administered via nebulizer over 5-15 minutes, often for more acute or severe exacerbations.</li>
                                        <li>Oral syrup and tablets: Oral formulations are also available but less common, especially for acute relief. Oral syrup or tablets at doses of 2 ‚Äì 6 mg two to three times daily (tid ‚Äì qid) may be used for maintenance therapy or in children.</li>
                                    </ul>
                                </li>
                                <li>Tocolytic in preterm labor: To delay premature labor by relaxing uterine smooth muscle contractions.
                                    <ul>
                                        <li>Subcutaneous injection or IV infusion: For tocolysis, administered via subcutaneous injection or continuous intravenous infusion in a hospital setting to manage preterm labor contractions. Dosage is carefully titrated and monitored.</li>
                                    </ul>
                                </li>
                            </ol>
                        </div>
                    </section>
                </div>
            </section>

            <section class="content-section">
                <h2>üìö Contraindications and Precautions of Terbutaline sulfate</h2>
                <div class="content-block">
                    <section class="content-section">
                        <h3>Contraindications</h3>
                        <div class="content-block">
                            <ul>
                                <li>Hypersensitivity to drug or adrenergic amines: Patients with known allergy to terbutaline or other sympathomimetic amines.</li>
                            </ul>
                        </div>
                    </section>
                    <section class="content-section">
                        <h3>Precautions</h3>
                        <div class="content-block">
                            <p>Use cautiously in patients with:</p>
                            <ul>
                                <li>Cardiovascular disorders: Including hypertension, coronary artery disease, arrhythmias, as beta-agonists can exacerbate these conditions due to cardiovascular stimulation.</li>
                                <li>Diabetes mellitus: May cause hyperglycemia, requiring closer monitoring of blood glucose levels and adjustment of diabetic medications.</li>
                                <li>Seizure disorders: May lower seizure threshold, increasing risk of seizures in susceptible individuals.</li>
                                <li>Elderly patients: Elderly patients may be more sensitive to the adrenergic side effects.</li>
                                <li>Breastfeeding patients: Terbutaline passes into breast milk; use should be cautious due to potential effects on the infant.</li>
                            </ul>
                        </div>
                    </section>
                </div>
            </section>

            <section class="content-section">
                <h2>üìö Side effects and Patient monitoring of Terbutaline sulfate</h2>
                <div class="content-block">
                    <section class="content-section">
                        <h3>Side effects:</h3>
                        <div class="content-block">
                            <ul>
                                <li>Central Nervous System (CNS): Tremors (most common), anxiety, nervousness, restlessness, insomnia, headache, dizziness, drowsiness. CNS stimulation is due to adrenergic effects.</li>
                                <li>Cardiovascular (CV): Palpitations, tachycardia (rapid heart rate), angina pain (chest pain), arrhythmias (irregular heartbeat), hypertension. Cardiovascular effects are due to Œ≤1-adrenergic receptor stimulation, although terbutaline is Œ≤2-selective, some Œ≤1 stimulation can occur, especially at higher doses.</li>
                                <li>Gastrointestinal (GI): Nausea, vomiting.</li>
                                <li>Other: Skin diaphoresis (sweating), flushing.</li>
                            </ul>
                        </div>
                    </section>
                    <section class="content-section">
                        <h3>Patient monitoring</h3>
                        <div class="content-block">
                            <ul>
                                <li>Monitor vital signs: Regularly monitor vital signs, particularly heart rate and blood pressure, for cardiovascular effects.</li>
                                <li>Assess neurologic status: Assess for CNS side effects such as tremors, anxiety, and dizziness, especially when initiating therapy or adjusting dosage.</li>
                            </ul>
                        </div>
                    </section>
                </div>
            </section>

            <section class="practice-activity">
                <h2>‚úçÔ∏è Practice Exercise</h2>
                <div class="content-activity">
                    <p><strong>Question:</strong> Explain the selective beta-2 adrenergic agonist action of Terbutaline sulfate in treating bronchial asthma. What are the advantages of using a selective Œ≤2-agonist like Terbutaline compared to a non-selective adrenergic agonist like Epinephrine for asthma relief?</p>
                    <details class="solution">
                        <summary>View Solution</summary>
                        <div class="solution-content">
                            <p><strong>Selective Beta-2 Adrenergic Agonist Action of Terbutaline Sulfate in Treating Bronchial Asthma:</strong> Terbutaline sulfate is a selective beta-2 (Œ≤2) adrenergic agonist, meaning it primarily targets and activates Œ≤2 receptors. This selectivity is key to its effectiveness in treating bronchial asthma because Œ≤2 receptors are predominantly found in bronchial smooth muscle, where their activation leads to bronchodilation.</p>
                            <p><strong>Mechanism of Action in Asthma:</strong></p>
                            <ul>
                                <li>Œ≤2 Receptor Stimulation: Terbutaline selectively binds to and activates Œ≤2-adrenergic receptors on bronchial smooth muscle cells.</li>
                                <li>Increased Intracellular cAMP: Activation of Œ≤2 receptors stimulates intracellular adenylate cyclase, increasing the production of cyclic adenosine monophosphate (cAMP).</li>
                                <li>Bronchial Smooth Muscle Relaxation: Increased cAMP levels lead to relaxation of bronchial smooth muscle. This relaxation causes bronchodilation, which widens the airways, reduces airway resistance, and improves airflow to and from the lungs.</li>
                                <li>Reduced Airway Resistance: By relaxing bronchial smooth muscles, terbutaline effectively reverses bronchospasm, a key component of asthma, thereby alleviating symptoms like wheezing, shortness of breath, and chest tightness.</li>
                                <li>Inhibition of Mediator Release: Additionally, Œ≤2-agonists like terbutaline can inhibit the release of inflammatory mediators from mast cells and basophils in the airways, which helps to reduce inflammation and allergic responses in the lungs, contributing to overall bronchodilation and symptom relief in asthma.</li>
                            </ul>
                            <p><strong>Advantages of Selective Œ≤2-Agonist (Terbutaline) over Non-Selective Adrenergic Agonist (Epinephrine) for Asthma Relief:</strong></p>
                            <ul>
                                <li>Reduced Cardiovascular Side Effects:
                                    <ul>
                                        <li>Selectivity for Œ≤2 Receptors: Terbutaline's selectivity for Œ≤2 receptors over Œ≤1 receptors provides a significant advantage. Œ≤1 receptors are mainly in the heart, and their stimulation leads to increased heart rate and contractility, which can be problematic, especially in patients with cardiac conditions.</li>
                                        <li>Less Cardiac Stimulation: Because Albuterol is Œ≤2-selective, it produces bronchodilation with less stimulation of Œ≤1 receptors, resulting in fewer cardiovascular side effects like tachycardia and palpitations compared to non-selective agonists like epinephrine.</li>
                                    </ul>
                                </li>
                                <li>Targeted Bronchodilation:
                                    <ul>
                                        <li>Primary Bronchodilator Effect: Albuterol‚Äôs primary therapeutic effect is bronchodilation, precisely what is needed in asthma to open airways. Its selectivity ensures that the bronchodilatory effect is maximized while minimizing systemic adrenergic side effects.</li>
                                        <li>Epinephrine's Broader Effects: Epinephrine, being non-selective, stimulates both alpha and beta receptors, leading to a wide range of systemic effects, including significant cardiovascular stimulation (increased heart rate, blood pressure) due to Œ±1 and Œ≤1 activation, in addition to bronchodilation (Œ≤2 effect). While effective in emergencies like anaphylaxis, its non-selectivity increases the risk of cardiovascular side effects, making it less suitable for routine asthma management compared to Œ≤2-selective agonists like albuterol.</li>
                                    </ul>
                                </li>
                            </ul>
                        </div>
                    </details>
                </div>
            </section>
        </main>

        <footer class="module-footer">
            <section class="key-takeaways">
                <h2>üìö Key Takeaways</h2>
                <ul>
                    <li>Terbutaline sulfate (Bricanyl, Ventolin) is a selective Œ≤2-adrenergic agonist, primarily used as a bronchodilator in asthma and COPD, and as a tocolytic.</li>
                    <li>Administered via inhalation, nebulization, or oral routes; side effects include tremors, anxiety, tachycardia. Contraindicated in hypersensitivity.</li>
                    <li>Nursing care involves monitoring vital signs, assessing neurologic status, educating patients on inhaler technique, and advising caution due to potential CNS and cardiovascular side effects.</li>
                </ul>
            </section>

            <section class="knowledge-check">
                <h2>‚ö° Knowledge Check</h2>
                <div class="quiz-content">
                    <ol>
                        <li>Terbutaline sulfate is classified as a selective:
                            <br> a) Alpha-1 adrenergic agonist <br> b) Beta-1 adrenergic agonist <br> c) Beta-2 adrenergic agonist</li>
                        <li>The primary therapeutic use of Terbutaline sulfate is to treat:
                            <br> a) Hypertension <br> b) Bronchial asthma <br> c) Bradycardia</li>
                        <li>A common side effect of Terbutaline sulfate due to beta-adrenergic stimulation is:
                            <br> a) Drowsiness <br> b) Tremors <br> c) Hypotension</li>
                    </ol>
                </div>
            </section>
        </footer>
    </article>
</body>
</html>